feed,title,long_url,short_url
Benzinga,'Highly Compelling' Eye Drug Data Has Wall Street Stampeding To Buy This 'Large Cap Growth Story.' Even After $15B In Market Cap Was Added,https://benzinga.com/general/biotech/22/09/28811913/regeneron-earns-price-target-boosts-upgrades-after-positive-aflibercept-8-mg-data,https://bit.ly/3eEXZJF
